关注
Dirk De Ruysscher
Dirk De Ruysscher
Maastro, Maastricht University Medical Center+, University Maastricht and Erasmus MC, Rotterdam, The
在 maastro.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Small-cell lung cancer
JP Van Meerbeeck, DA Fennell, DKM De Ruysscher
The Lancet 378 (9804), 1741-1755, 2011
12272011
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
A Brunelli, A Charloux, CT Bolliger, G Rocco, JP Sculier, G Varela, ...
European Respiratory Journal 34 (1), 17-41, 2009
9042009
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Reck, S Popat, N Reinmuth, D De Ruysscher, KM Kerr, S Peters
Annals of oncology 25, iii27-iii39, 2014
7922014
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Früh, D De Ruysscher, S Popat, L Crinò, S Peters, E Felip
Annals of oncology 24, vi99-vi105, 2013
6952013
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J Vansteenkiste, D De Ruysscher, WEE Eberhardt, E Lim, S Senan, ...
Annals of oncology 24, vi89-vi98, 2013
6392013
Radiotherapy toxicity
D De Ruysscher, G Niedermann, NG Burnet, S Siva, AWM Lee, ...
Nature Reviews Disease Primers 5 (1), 13, 2019
6302019
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
K Reynders, T Illidge, S Siva, JY Chang, D De Ruysscher
Cancer treatment reviews 41 (6), 503-510, 2015
6112015
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
5492014
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach
JA Langendijk, P Lambin, D De Ruysscher, J Widder, M Bos, M Verheij
Radiotherapy and Oncology 107 (3), 267-273, 2013
5362013
European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer
D De Ruysscher, C Faivre-Finn, U Nestle, CW Hurkmans, C Le Péchoux, ...
Journal of clinical oncology 28 (36), 5301-5310, 2010
495*2010
Predicting outcomes in radiation oncology—multifactorial decision support systems
P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ...
Nature reviews Clinical oncology 10 (1), 27-40, 2013
4492013
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ...
Journal of Clinical Oncology 24 (7), 1057-1063, 2006
4222006
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
4132015
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis
JPC Grutters, AGH Kessels, M Pijls-Johannesma, D De Ruysscher, ...
Radiotherapy and Oncology 95 (1), 32-40, 2010
4032010
Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, JM Bravo-San Pedro, ...
Frontiers in immunology 6, 588, 2015
3942015
Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures
RTHM Larue, G Defraene, D De Ruysscher, P Lambin, W Van Elmpt
The British journal of radiology 90 (1070), 20160665, 2017
3862017
Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer after …
WEE Eberhardt, C Pöttgen, TC Gauler, G Friedel, S Veit, V Heinrich, ...
Journal of Clinical Oncology 33 (35), 4194-4201, 2015
3642015
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ...
Annals of Oncology 25 (9), 1681-1690, 2014
3642014
Pet-ct–based auto-contouring in non–small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved …
A Van Baardwijk, G Bosmans, L Boersma, J Buijsen, S Wanders, ...
International Journal of Radiation Oncology* Biology* Physics 68 (3), 771-778, 2007
3392007
Radical treatment of non–small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450)
D De Ruysscher, R Wanders, A van Baardwijk, AMC Dingemans, ...
Journal of Thoracic Oncology 7 (10), 1547-1555, 2012
3212012
系统目前无法执行此操作,请稍后再试。
文章 1–20